Cargando…

Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge

Ebola virus is the primary contributor to the global threat of filovirus severe hemorrhagic fever, and Ebola virus disease has a case fatality rate of 50–90%. An inactivated, bivalent filovirus/rabies virus vaccine, FILORAB1, consists of recombinant rabies virus virions expressing the Ebola virus gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yankowski, Catherine, Kurup, Drishya, Wirblich, Christoph, Schnell, Matthias J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906604/ https://www.ncbi.nlm.nih.gov/pubmed/36754965 http://dx.doi.org/10.1038/s41541-023-00615-z

Ejemplares similares

Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity
por: Yankowski, Catherine, et al.
Publicado: (2022)

Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2
por: Kurup, Drishya, et al.
Publicado: (2020)

Rabies-based vaccine induces potent immune responses against Nipah virus
por: Keshwara, Rohan, et al.
Publicado: (2019)

Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model
por: Kurup, Drishya, et al.
Publicado: (2021)

The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees?
por: Walsh, Peter D., et al.
Publicado: (2017)

Publisher Correction: Rabies-based vaccine induces potent immune responses against Nipah virus
por: Keshwara, Rohan, et al.
Publicado: (2019)

A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model
por: Kurup, Drishya, et al.
Publicado: (2022)

Rabies Virus as a Research Tool and Viral Vaccine Vector
por: Gomme, Emily A., et al.
Publicado: (2011)

Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
por: Blaney, Joseph E., et al.
Publicado: (2013)

Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract
por: Kurup, Drishya, et al.
Publicado: (2022)

Current vaccine strategies against SARS-CoV-2: Promises and challenges
por: Kurup, Drishya, et al.
Publicado: (2022)

A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19
por: Malherbe, Delphine C., et al.
Publicado: (2021)

YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge
por: Lemmens, Viktor, et al.
Publicado: (2023)

SARS-CoV-2 vaccines — the biggest medical research project of the 21st century
por: Kurup, Drishya, et al.
Publicado: (2021)

Non-neutralizing antibodies elicited by recombinant Lassa–Rabies vaccine are critical for protection against Lassa fever
por: Abreu-Mota, Tiago, et al.
Publicado: (2018)

Immune Clearance of Attenuated Rabies Virus Results in Neuronal Survival with Altered Gene Expression
por: Gomme, Emily A., et al.
Publicado: (2012)

Retrograde axonal transport of rabies virus is unaffected by interferon treatment but blocked by emetine locally in axons
por: MacGibeny, Margaret A., et al.
Publicado: (2018)

Rabies Virus Infection Induces Type I Interferon Production in an IPS-1 Dependent Manner While Dendritic Cell Activation Relies on IFNAR Signaling
por: Faul, Elizabeth J., et al.
Publicado: (2010)

Virus-Vectored Ebola Vaccines
por: Dolzhikova, I.V., et al.
Publicado: (2017)

Rabies virus glycoprotein as a carrier for anthrax protective antigen
por: Smith, Mary Ellen, et al.
Publicado: (2006)

Lyssavirus Vaccine with a Chimeric Glycoprotein Protects across Phylogroups
por: Fisher, Christine R., et al.
Publicado: (2020)

Rabies-Specific Antibodies: Measuring Surrogates of Protection against a Fatal Disease
por: Moore, Susan M., et al.
Publicado: (2010)

Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
por: Matassov, Demetrius, et al.
Publicado: (2015)

Identification of Novel Adjuvants for Ebola Virus-Like Particle Vaccine
por: Feng, Huapeng, et al.
Publicado: (2020)

Isatis indigotica root polysaccharides as adjuvants for an inactivated rabies virus vaccine
por: Zhang, Weijiao, et al.
Publicado: (2016)

Inactivated Rabies Virus Vectored MERS-Coronavirus Vaccine Induces Protective Immunity in Mice, Camels, and Alpacas
por: Chi, Hang, et al.
Publicado: (2022)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

Progress in Elucidating Potential Markers and Mechanisms of Rapid Protection Conferred by the VSV-Vectored Ebola Virus Vaccine
por: Wong, Gary
Publicado: (2019)

Outer membrane proteins of Salmonella typhimurium as an adjuvant in rabies vaccine
por: Negm, Iman Ibrahim, et al.
Publicado: (2021)

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine
por: Santoro, Francesco, et al.
Publicado: (2021)

Rabies vaccine and immunoglobulin supply and logistics: Challenges and opportunities for rabies elimination in Kenya
por: Wambura, Gati, et al.
Publicado: (2019)

Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge
por: Takayama-Ito, Mutsuyo, et al.
Publicado: (2018)

Green synthesis and evaluation of silver nanoparticles as adjuvant in rabies veterinary vaccine
por: Asgary, Vahid, et al.
Publicado: (2016)

β-Glucan as Trained Immunity-Based Adjuvants for Rabies Vaccines in Dogs
por: Paris, Simon, et al.
Publicado: (2020)

Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines
por: Chen, Chen, et al.
Publicado: (2019)

Ebola Virus Disease Vaccines: Development, Current Perspectives & Challenges
por: Malik, Sumira, et al.
Publicado: (2023)

Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease
por: Perry, Donna L., et al.
Publicado: (2018)

Protection of Mice Against Lethal Rabies Virus Challenge Using Short Interfering RNAs (siRNAs) Delivered Through Lentiviral Vector
por: Singh, Niraj K., et al.
Publicado: (2013)

Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
por: Marzi, Andrea, et al.
Publicado: (2016)

Bacillus subtilis vector based oral rabies vaccines induced potent immune response and protective efficacy in mice
por: Zhang, Ying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qi4n7edbun8ah8uj797j7fpouv